UVB irradiation down-regulates HPV-16 RNA expression: Implications for malignant progression of transformed cells

Virus Research

Volumn 130, Issue 1-2, 2007, Pages 249-259

  De Marco, Federico ^a   Perluigi, Marzia ^b   Foppoli, Cesira ^c   Blarzino, Carla ^b   Cini, Chiara ^b   Coccia, Raffaella ^b   Venuti, Aldo ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CNR   (Italy)

Author keywords

HPV RNA transcription; Keratinocytes; Oxidative stress; UVB irradiation; Viral oncogenes

Indexed keywords

SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; CELL REGENERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION; VIRUS TRANSCRIPTION;

ANTIOXIDANTS; CELL LINE; DNA REPAIR; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; OXIDATIVE STRESS; TRANSFECTION; ULTRAVIOLET RAYS; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 35948966798     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.06.018     Document Type: Article

References (53)

1. Ananthaswamy H.N., and Pierceall W.E. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 52 (1990) 1119-1136
2. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., and Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61 (1987) 962-971
3. Baker C., and Calef C. Maps of papillomavirus mRNA transcripts. In: Mayers H.D., Icenogel J., Bernard H.U., Baker C., Halpern A., and Wheeler C. (Eds). Human Papilloma Viruses 1996 Compendium (1996), Los Alamos, New Mexico, USA
4. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
5. Bouvard V., Storey A., Pim D., and Banks L. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 13 (1994) 5451-5459
6. Breimer L.H. Repair of DNA damage induced by reactive oxygen species. Free Radic. Res. Commun. 14 (1991) 159-171
7. Carraro C., and Pathak M.A. Characterization of superoxide dismutase from mammalian skin epidermis. J. Invest. Dermatol. 90 (1988) 31-36
8. Chouinard N., Valerie K., Rouabhia M., and Huot J. UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53. Biochem. J. 365 (2002) 133-145
9. Danno K., Horio T., Takigawa M., and Imamura S. Role of oxygen intermediates in UV-induced epidermal cell injury. J. Invest. Dermatol. 83 (1984) 166-168
10. Darr D., and Fridovich I. Free radicals in cutaneous biology. J. Invest. Dermatol. 102 (1994) 671-675
11. Das B.C., Sharma J.K., Gopalakrishna V., and Luthra U.K. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. Gen. Virol. 73 Pt 9 (1992) 2327-2336
12. De Marco F., and Marcante M.L. HPV-16 E6-E7 differential transcription induced in Siha cervical cancer cell line by interferons. J. Biol. Regul. Homeost. Agents 7 (1993) 15-21
13. Desaintes C., Goyat S., Garbay S., Yaniv M., and Thierry F. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene 18 (1999) 4538-4545
14. Dondi E., Pattyn E., Lutfalla G., Van Ostade X., Uze G., Pellegrini S., and Tavernier J. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase. J. Biol. Chem. 276 (2001) 47004-47012
15. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
16. Durst M., Glitz D., Schneider A., and zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189 (1992) 132-140
17. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
18. Ernster L. DT-diaphorase. In: Eastbrook R.W., and Pullman M.E. (Eds). Methods in Enzymology 10 (1967), Academic Press, New York 309-317
19. Favre M., Majewski S., De Jesus N., Malejczyk M., Orth G., and Jablonska S. A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J. Invest. Dermatol. 111 (1998) 333-336
20. Foppoli C., De Marco F., Blarzino C., Perluigi M., Cini C., and Coccia R. Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1. Int. J. Biochem. Cell Biol. 37 (2005) 852-863
21. Gerlier D., and Thomassset N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 94 (1986) 5763-5769
22. Güner G., Islekel H., Oto O., Hazan E., and Acikel U. Evaluation of some antioxidant enzymes in lung carcinoma tissue. Cancer Lett. 103 (1996) 233-239
23. Harrison D.G., Widder J., Grumbach I., Chen W., Weber M., and Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J. Intern. Med. 259 (2006) 351-363
24. He Y.H., Xu Y., Kobune M., Wu M., Kelley M.R., and Martin II W.J. Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002) L50-L55
25. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., and Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28 (2000) 1456-1462
26. Johnson M.A., Blomfield P.I., Bevan I.S., Woodman C.B., and Young L.S. Analysis of human papillomavirus type 16 E6-E7 transcription in cervical carcinomas and normal cervical epithelium using the polymerase chain reaction. J. Gen. Virol. 71 Pt 7 (1990) 1473-1479
27. Jung E.J., Liu G., Zhou W., and Chen X. Myosin VI is a mediator of the p53-dependent cell survival pathway. Mol. Cell Biol. 26 (2006) 2175-2186
28. Jurkiewicz B.A., and Buettner G.R. Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study. Photochem. Photobiol. 59 (1994) 1-4
29. Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A., Lotz B., Melsheimer P., and von Knebel Doeberitz M. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59 (1999) 6132-6136
30. Kondo S., Toyokuni S., Tanaka T., Hiai H., Onodera H., Kasai H., and Imamura M. Overexpression of the hOGG1 gene and high 8-hydroxy-2′-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: regulation mechanism of the 8-OHdG level in DNA. Clin. Cancer Res. 6 (2000) 1394-1400
31. Lehman T.A., Modali R., Boukamp P., Stanek J., Bennett W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N., Rogan E.M., et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14 (1993) 833-839
32. Mandel S.A., Avramovich-Tirosh Y., Reznichenko L., Zheng H., Weinreb O., Amit T., and Youdim M.B. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14 (2005) 46-60
33. Miyachi Y. Photoaging from an oxidative standpoint. J. Dermatol. Sci. 9 (1995) 79-86
34. Romanczuk H., Thierry F., and Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64 (1990) 2849-2859
35. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., Mullis K.B., and Erlich H.A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239 (1988) 487-491
36. Schutte B., Henfling M., Kolgen W., Bouman M., Meex S., Leers M.P., Nap M., Bjorklund V., Bjorklund P., Bjorklund B., Lane E.B., Omary M.B., Jornvall H., and Ramaekers F.C. Keratin 8/18 breakdown and reorganization during apoptosis. Exp. Cell Res. 297 (2004) 11-26
37. Sherman L., Alloul N., Golan I., Durst M., and Baram A. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int. J. Cancer 50 (1992) 356-364
38. Siemankowski L.M., Morreale J., Butts B.D., and Briehl M.M. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase. Cancer Res. 60 (2000) 3638-3644
39. Steger G., and Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71 (1997) 50-58
40. Taylor E.R., Boner W., Dornan E.S., Corr E.M., and Morgan I.M. UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein. Oncogene 22 (2003) 4469-4477
41. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L1005-L1028
42. Vance K.W., Campo M.S., and Morgan I.M. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J. Virol. 75 (2001) 2829-2838
43. Venuti A., and Marcante M.L. Presence of human papillomavirus type 18 DNA in vulvar carcinomas and its integration into the cell genome. J. Gen. Virol. 70 (1898) 1587-1592
44. Venuti A., Marcante M.L., Flamini S., Di Castro V., and Bagnato A. The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop. J. Virol. 71 (1997) 6898-6904
45. Venuti A., and Campo M.S. The E5 Proteins of Papillomaviruses. In: McCance D.J. (Ed). Perspectives in Medical Virology: Human Papillomaviruses (2002), Elsevier Science B.V., Amsterdam 143-164
46. Vousden K.H. Outcomes of p53 activation-spoilt for choice. J. Cell Sci. 119 (2006) 5015-5020
47. Webster K., Parish J., Pandya M., Stern P.L., Clarke A.R., and Gaston K. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 275 (2000) 87-94
48. Woodworth C.D., Bowden P.E., Doniger J., Pirisi L., Barnes W., Lancaster W.D., and Di Paolo J.A. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res. 48 (1988) 4620-4628
49. Wu W.S., Heinrichs S., Xu D., Garrison S.P., Zambetti G.P., and Adams J.M. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123 (2005) 641-653
50. Yoshinouchi M., Hongo A., Nakamura K., Kodama J., Itoh S., Sakai H., and Kudo T. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J. Clin. Microbiol. 37 (1999) 3514-3517
51. Yoshioka A., Miyachi Y., and Imamura S. Mechanisms of reactive oxygen species-induced skin erythema and superoxide dismutase activities in guinea pigs. J. Dermatol. 14 (1987) 569-575
52. zur Hausen H. Viruses in human cancers. Eur. J. Cancer 35 (1999) 1878-1885
53. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350